glp-1 for diabetes type 2 GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Clinical Focus on GLP-1 Agonists

If you have a personal or family history of thyroid tumors (specifically medullary thyroid carcinoma), make sure your healthcare professional knows

How effective are medical weight loss programs in clinical trials

Therefore, the use of NSAIDs is usually associated with damage to the gastrointestinal tract and other systems during treatment, and thus need to be used with caution (95)

Lighter than normal, and nothing youd regret on a slow stomach

Similarly, the 4 SLGT2i CVOTs completed to date have also shown non-inferiority for cardiovascular safety compared with placebo, and in some cases showed impressive reductions in adverse cardiovascular outcomes